Wang C, Huang L, Li R, Wang Y, Wu X, Shang D (2021a) Synergistic therapy of doxorubicin with cationic anticancer peptide L-K6 reverses multidrug resistance in MCF-7/ADR cancer cells in vitro via P-glycoprotein inhibition
Skip navigation Show Navigation Show cart Our Story Products Research & Education Learn More Cart Shop Now
Buyer assumes full responsibility for end-use compliance within their jurisdiction.
R.RajabiZ.AkbariM.HassanzadehG.MohseniA.EramsadatiM
Consumption of these products has resulted in numerous hospitalizations, [2] and the drugs have been reported to cause hallucinations, increased heartbeat and blood pressure, aggressive behavior, anxiety, muscle spasms, nausea, and vomiting